Comparison of Semaglutide or Dulaglutide Versus Empagliflozin for Risk for Death and Cardiovascular Outcomes Among Patients With Type 2 Diabetes : Two Target Trial Emulation Studies.
Annals of internal medicine. 2025 Jun; doi: 10.7326/ANNALS-24-00775. pii: .
Base: PUBMEDTirzepatide as Compared with Semaglutide for the Treatment of Obesity.
The New England journal of medicine. 2025 Jul; 393(Jul):26-36. doi: 10.1056/NEJMoa2416394. pii: .
Base: PUBMED[Management of follicular cell-derived thyroid cancer in 2025].
Revue medicale suisse. 2025 Jun; 21(Jun):1210-1215. doi: 10.53738/REVMED.2025.21.922.47328. pii: .
Base: PUBMEDTirzepatide and cardiometabolic parameters in obesity: Summary of current evidence.
Diabetes, obesity & metabolism. 2025 Jun; doi: 10.1111/dom.16549. pii: .
Base: PUBMEDPharmacologic options for the treatment of overweight and obesity.
Menopause (New York, N.Y.). 2025 Jun; doi: 10.1097/GME.0000000000002573. pii: .
Base: PUBMEDTirzepatide for Obesity Treatment and Diabetes Prevention.
The New England journal of medicine. 2025 Jun; 392(Jun):2491-2492. doi: 10.1056/NEJMc2504728. pii: 10.1056/NEJMc2504728#sa1.
Base: PUBMEDApproach to the Patient With Cyclical Cushing Syndrome.
The Journal of clinical endocrinology and metabolism. 2025 Jun; 110(Jun):e2338-e2346. doi: 10.1210/clinem/dgae864. pii: .
Base: PUBMEDApproach to Lipid Management in the Patient With Diabetes.
The Journal of clinical endocrinology and metabolism. 2025 May; 110(May):1740-1755. doi: 10.1210/clinem/dgaf018. pii: .
Base: PUBMEDDiabetes Deprescribing in Older Adults: A Randomized Clinical Trial.
JAMA internal medicine. 2025 Jun; doi: 10.1001/jamainternmed.2025.2015. pii: e252015.
Base: PUBMEDHypoparathyroidism: diagnosis, management and emerging therapies.
Nature reviews. Endocrinology. 2025 Jun; 21(Jun):360-374. doi: 10.1038/s41574-024-01075-8. pii: .
Base: PUBMEDGenetic origin of multifocal sporadic medullary thyroid cancer and C-cell hyperplasia.
European journal of endocrinology. 2025 May; 192(May):737-743. doi: 10.1093/ejendo/lvaf109. pii: .
Base: PUBMEDLess is more: once vs. multiple radioactive iodine (RAI) therapy in patients with RAI-avid pulmonary micrometastatic differentiated thyroid cancer.
European journal of nuclear medicine and molecular imaging. 2025 May; doi: 10.1007/s00259-025-07339-3. pii: .
Base: PUBMEDThe diagnostic challenges of medullary thyroid carcinoma: A practical guide for cytopathologists.
Cancer cytopathology. 2025 Jun; 133(Jun):e70023. doi: 10.1002/cncy.70023. pii: e70023.
Base: PUBMEDThe utility of 68Ga-DOTATATE and 18F-FDG PET/CT in predicting the response to tyrosine kinase inhibitors in patients with advanced medullary thyroid cancer.
Thyroid research. 2025 Jun; 18(Jun):31. doi: 10.1186/s13044-025-00250-x. pii: 31.
Base: PUBMEDAdjuvant External Beam Radiotherapy Reduces Local Recurrence in Poorly Differentiated Thyroid Cancer : A Multicenter Retrospective Cohort Study Describing Outcomes in the Treatment of Resectable Poorly Differentiated Thyroid Cancer.
Annals of surgical oncology. 2025 May; doi: 10.1245/s10434-025-17434-2. pii: .
Base: PUBMEDASO Visual Abstract: Adjuvant External Beam Radiotherapy Reduces Local Recurrence in Poorly Differentiated Thyroid Cancer : A Multicenter Retrospective Cohort Study Describing Outcomes in the Treatment of Resectable Poorly Differentiated Thyroid Cancer.
Annals of surgical oncology. 2025 Jun; doi: 10.1245/s10434-025-17583-4. pii: .
Base: PUBMEDNew obesity definition sidelines BMI to focus on health.
Nature. 2025 Jan; 637(Jan):773-774. doi: 10.1038/d41586-025-00123-1. pii: .
Base: PUBMEDDefinition and diagnostic criteria of clinical obesity.
The lancet. Diabetes & endocrinology. 2025 Mar; 13(Mar):221-262. doi: 10.1016/S2213-8587(24)00316-4. pii: S2213-8587(24)00316-4.
Base: PUBMEDThe Venice Declaration: Obesity as a Disease-A Call to Action for Diagnosis, Multimodal Treatment, and Policy Change.
Obesity surgery. 2025 Apr; doi: 10.1007/s11695-025-07869-7. pii: .
Base: PUBMEDBasal and Stimulated Inhibin B in Pubertal Disorders.
The Journal of clinical endocrinology and metabolism. 2025 Jun; 110(Jun):e2136-e2145. doi: 10.1210/clinem/dgaf005. pii: .
Base: PUBMEDAdult Height Following Prepubertal Treatment With Antiandrogen, Aromatase Inhibitor, and Reduced Hydrocortisone in CAH.
The Journal of clinical endocrinology and metabolism. 2025 Jun; 110(Jun):e2171-e2182. doi: 10.1210/clinem/dgae824. pii: .
Base: PUBMEDApproach to the Patient with Achondroplasia-New Considerations for Diagnosis, Management, and Treatment.
The Journal of clinical endocrinology and metabolism. 2025 Jun; 110(Jun):e2309-e2316. doi: 10.1210/clinem/dgaf017. pii: .
Base: PUBMEDAnastrozole Improves Height Outcomes in Growing Children With Congenital Adrenal Hyperplasia Due to 21-hydroxylase Deficiency.
The Journal of clinical endocrinology and metabolism. 2025 Jun; 110(Jun):e2198-e2207. doi: 10.1210/clinem/dgae771. pii: .
Base: PUBMEDGestational Diabetes Mellitus: Mechanisms Underlying Maternal and Fetal Complications.
Endocrinology and metabolism (Seoul, Korea). 2025 Feb; 40(Feb):10-25. doi: 10.3803/EnM.2024.2264. pii: .
Base: PUBMEDFSH and Sertoli cell biomarkers accurately distinguish hypogonadotropic hypogonadism from self-limited delayed puberty.
The Journal of clinical endocrinology and metabolism. 2025 Feb; doi: 10.1210/clinem/dgaf062. pii: dgaf062.
Base: PUBMEDManaging obesity in children: a clinical practice guideline.
CMAJ : Canadian Medical Association journal = journal de l'Association medicale canadienne. 2025 Apr; 197(Apr):E372-E389. doi: 10.1503/cmaj.241456. pii: .
Base: PUBMED9. Pharmacologic Approaches to Glycemic Treatment: Standards of Care in Diabetes-2025.
Diabetes care. 2025 Jan; 48(Jan):S181-S206. doi: 10.2337/dc25-S009. pii: .
Base: PUBMEDAmerican Association of Clinical Endocrinology Clinical Practice Guideline on Pharmacologic Management of Adults With Dyslipidemia.
Endocrine practice : official journal of the American College of Endocrinology and the American Association of Clinical Endocrinologists. 2025 Feb; 31(Feb):236-262. doi: 10.1016/j.eprac.2024.09.016. pii: S1530-891X(24)00691-8.
Base: PUBMEDHyperglycemic crises in adults: A look at the 2024 consensus report.
Cleveland Clinic journal of medicine. 2025 Mar; 92(Mar):152-158. doi: 10.3949/ccjm.92a.24089. pii: .
Base: PUBMEDHighlights of the 2025 American Association of Clinical Endocrinology Clinical Practice Guideline on Pharmacologic Management of Adults With Dyslipidemia.
Endocrine practice : official journal of the American College of Endocrinology and the American Association of Clinical Endocrinologists. 2024 Dec; doi: 10.1016/j.eprac.2024.11.006. pii: S1530-891X(24)00831-0.
Base: PUBMEDScreening for Osteoporosis to Prevent Fractures: US Preventive Services Task Force Recommendation Statement.
JAMA. 2025 Feb; 333(Feb):498-508. doi: 10.1001/jama.2024.27154. pii: .
Base: PUBMEDCompounded GLP-1 and Dual GIP/GLP-1 Receptor Agonists: A Statement from the American Diabetes Association.
Diabetes care. 2025 Feb; 48(Feb):177-181. doi: 10.2337/dci24-0091. pii: .
Base: PUBMEDEvaluation of the evidence-based practices for the management of PCOS in the Latin America context: the consensus of the Latin American Association of Gynecological Endocrinology (ALEG).
Gynecological endocrinology : the official journal of the International Society of Gynecological Endocrinology. 2025 Dec; 41(Dec):2456578. doi: 10.1080/09513590.2025.2456578. pii: .
Base: PUBMED2. Diagnosis and Classification of Diabetes: Standards of Care in Diabetes-2025.
Diabetes care. 2025 Jan; 48(Jan):S27-S49. doi: 10.2337/dc25-S002. pii: .
Base: PUBMED4. Comprehensive Medical Evaluation and Assessment of Comorbidities: Standards of Care in Diabetes-2025.
Diabetes care. 2025 Jan; 48(Jan):S59-S85. doi: 10.2337/dc25-S004. pii: .
Base: PUBMED6. Glycemic Goals and Hypoglycemia: Standards of Care in Diabetes-2025.
Diabetes care. 2025 Jan; 48(Jan):S128-S145. doi: 10.2337/dc25-S006. pii: .
Base: PUBMED7. Diabetes Technology: Standards of Care in Diabetes-2025.
Diabetes care. 2025 Jan; 48(Jan):S146-S166. doi: 10.2337/dc25-S007. pii: .
Base: PUBMED13. Older Adults: Standards of Care in Diabetes-2025.
Diabetes care. 2025 Jan; 48(Jan):S266-S282. doi: 10.2337/dc25-S013. pii: .
Base: PUBMEDExogenous Opioids and the Human Endocrine System: An Endocrine Society Scientific Statement.
Endocrine reviews. 2024 Nov; 45(Nov):773-794. doi: 10.1210/endrev/bnae023. pii: .
Base: PUBMEDConsensus statement on the management of incidentally discovered FDG avid thyroid nodules in patients being investigated for other cancers.
Clinical endocrinology. 2024 Nov; 101(Nov):557-561. doi: 10.1111/cen.14905. pii: .
Base: PUBMEDClinician's Guide for Pediatric Anti-obesity Medications.
Pediatric clinics of North America. 2024 Oct; 71(Oct):957-980. doi: 10.1016/j.pcl.2024.07.006. pii: S0031-3955(24)00102-0.
Base: PUBMEDEuropean Society of Endocrinology and Endocrine Society Joint Clinical Guideline: Diagnosis and therapy of glucocorticoid-induced adrenal insufficiency.
European journal of endocrinology. 2024 May; 190(May):G25-G51. doi: 10.1093/ejendo/lvae029. pii: .
Base: PUBMEDConsensus Statement on Vitamin D Status Assessment and Supplementation: Whys, Whens, and Hows.
Endocrine reviews. 2024 Sep; 45(Sep):625-654. doi: 10.1210/endrev/bnae009. pii: .
Base: PUBMEDDCRM 2.0: Multispecialty practice recommendations for the management of diabetes, cardiorenal, and metabolic diseases.
Metabolism: clinical and experimental. 2024 Oct; 159(Oct):155931. doi: 10.1016/j.metabol.2024.155931. pii: S0026-0495(24)00158-6.
Base: PUBMEDDiabetic myocardial disorder. A clinical consensus statement of the Heart Failure Association of the ESC and the ESC Working Group on Myocardial & Pericardial Diseases.
European journal of heart failure. 2024 Jun; doi: 10.1002/ejhf.3347. pii: .
Base: PUBMEDEMAS position statement: Thyroid disease and menopause.
Maturitas. 2024 Jul; 185(Jul):107991. doi: 10.1016/j.maturitas.2024.107991. pii: S0378-5122(24)00086-0.
Base: PUBMEDInternational Guidelines for the Diagnosis and Management of Hyperinsulinism.
Hormone research in paediatrics. 2024 ; 97():279-298. doi: 10.1159/000531766. pii: .
Base: PUBMED[A consensus report by the Working Group on Eating Disorders of Sociedad Española de Nutrición Clínica y Metabolismo (GTTCA-SENPE). Evaluation, medical and nutritional management of anorexia nervosa. Update 2023].
Nutricion hospitalaria. 2024 Mar; 41(Mar):1-60. doi: 10.20960/nh.05175. pii: .
Base: PUBMEDGuidelines and Recommendations for Laboratory Analysis in the Diagnosis and Management of Diabetes Mellitus.
Diabetes care. 2023 Oct; 46(Oct):e151-e199. doi: 10.2337/dci23-0036. pii: .
Base: PUBMEDDiagnosis and management of prolactin-secreting pituitary adenomas: a Pituitary Society international Consensus Statement.
Nature reviews. Endocrinology. 2023 Dec; 19(Dec):722-740. doi: 10.1038/s41574-023-00886-5. pii: .
Base: PUBMEDTirzepatide as Compared with Semaglutide for the Treatment of Obesity.
The New England journal of medicine. 2025 Jul; 393(Jul):26-36. doi: 10.1056/NEJMoa2416394. pii: .
Base: PUBMEDEncouraging the prescribing of SGLT2i and GLP-1RA medications to reduce cardiovascular and renal risk in patients with type 2 diabetes: Rationale and design of a randomized controlled trial.
American heart journal. 2025 Jul; 285(Jul):39-51. doi: 10.1016/j.ahj.2025.02.007. pii: S0002-8703(25)00038-9.
Base: PUBMEDTirzepatide for Obesity Treatment and Diabetes Prevention.
The New England journal of medicine. 2025 Jun; 392(Jun):2491-2492. doi: 10.1056/NEJMc2504728. pii: 10.1056/NEJMc2504728#sa1.
Base: PUBMEDTirzepatide and cardiometabolic parameters in obesity: Summary of current evidence.
Diabetes, obesity & metabolism. 2025 Jun; doi: 10.1111/dom.16549. pii: .
Base: PUBMEDPharmacologic options for the treatment of overweight and obesity.
Menopause (New York, N.Y.). 2025 Jun; doi: 10.1097/GME.0000000000002573. pii: .
Base: PUBMEDDiabetes Deprescribing in Older Adults: A Randomized Clinical Trial.
JAMA internal medicine. 2025 Jun; doi: 10.1001/jamainternmed.2025.2015. pii: e252015.
Base: PUBMEDHormone therapy and insulin resistance in non-diabetic postmenopausal women: a systematic review and meta-analysis.
Climacteric : the journal of the International Menopause Society. 2025 Jun; 1-9. doi: 10.1080/13697137.2025.2509844. pii: .
Base: PUBMEDSelective Use of Radioiodine in Pediatric Thyroid Cancer-a Paradigm Shift.
The Journal of clinical endocrinology and metabolism. 2025 Jun; 110(Jun):e2403-e2404. doi: 10.1210/clinem/dgae656. pii: .
Base: PUBMEDAnastrozole Improves Height Outcomes in Growing Children With Congenital Adrenal Hyperplasia Due to 21-hydroxylase Deficiency.
The Journal of clinical endocrinology and metabolism. 2025 Jun; 110(Jun):e2198-e2207. doi: 10.1210/clinem/dgae771. pii: .
Base: PUBMEDApproach to the Patient With Thyroid Cancer: Selection and Management of Candidates for Lobectomy.
The Journal of clinical endocrinology and metabolism. 2025 Jun; 110(Jun):e2327-e2337. doi: 10.1210/clinem/dgae903. pii: .
Base: PUBMED